AU651569B2
(en)
|
1990-01-11 |
1994-07-28 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for detecting and modulating RNA activity and gene expression
|
EP0445749B1
(en)
|
1990-03-08 |
1996-07-10 |
Fujisawa Pharmaceutical Co., Ltd. |
N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments
|
WO1993021145A1
(en)
|
1992-04-21 |
1993-10-28 |
Ligand Pharmaceuticals Inc. |
Non-steroid progesterone receptor agonist and antagonist compounds and methods
|
GB9307694D0
(en)
|
1993-04-14 |
1993-06-02 |
Smithkine Beecham Corp |
Novel compounds
|
GB2291872A
(en)
|
1994-08-02 |
1996-02-07 |
Zeneca Ltd |
Alkyl cyclopentane-carboxylate fungicides
|
US5681940A
(en)
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
US5900415A
(en)
|
1994-11-07 |
1999-05-04 |
Pfizer Inc. |
Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands
|
AU692977B2
(en)
|
1994-11-07 |
1998-06-18 |
Pfizer Inc. |
Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands
|
DE19501482A1
(de)
|
1995-01-19 |
1996-07-25 |
Bayer Ag |
2,9-disubstituierte Purin-6-one
|
US5514505A
(en)
|
1995-05-15 |
1996-05-07 |
Xerox Corporation |
Method for obtaining improved image contrast in migration imaging members
|
WO1998003492A1
(en)
|
1996-07-23 |
1998-01-29 |
Neurogen Corporation |
Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
|
DK0918761T3
(da)
|
1996-07-23 |
2003-08-25 |
Neurogen Corp |
Visse amido- og aminosubstituerede benzylaminderivater, en ny klasse af neuropeptid Y1-specifikke ligander
|
JP2000515151A
(ja)
|
1996-07-23 |
2000-11-14 |
ニューロジェン・コーポレーション |
特定の置換ベンジルアミン誘導体;新規クラスの神経ペプチド―y1特異的リガンド
|
ATE271063T1
(de)
|
1996-10-16 |
2004-07-15 |
Icn Pharmaceuticals |
Purin-l-nukleoside, deren analoga und verwendungen
|
AU2095099A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists
|
AU2206499A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions
|
WO1999032486A1
(en)
|
1997-12-23 |
1999-07-01 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
WO1999032489A1
(en)
|
1997-12-23 |
1999-07-01 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
AU2307999A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
AU2206599A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Oximino-piperidine, -pyrrolidine and -azepine derivatives, their preparation andtheir use as muscarinic receptor (ant-)agonists
|
US6518305B1
(en)
|
1998-04-23 |
2003-02-11 |
Abbott Laboratories |
Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
|
WO1999054290A1
(en)
|
1998-04-23 |
1999-10-28 |
Abbott Laboratories |
Inhibitors of neuraminidases
|
BR9911048A
(pt)
|
1998-05-21 |
2001-02-06 |
Shionogi & Co |
Inibidor de spla2 de pirrolo[1,2-b]piridazina
|
US6268372B1
(en)
|
1998-09-11 |
2001-07-31 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
|
MXPA02001340A
(es)
|
1999-08-05 |
2004-07-16 |
Prescient Neuropharma Inc |
Compuestos novedosos 1,4-benzodiazepina y derivados de los mismos.
|
AU6473600A
(en)
|
1999-08-23 |
2001-03-19 |
Shionogi & Co., Ltd. |
Pyrrolotriazine derivatives having spla2-inhibitory activities
|
MXPA02001753A
(es)
|
1999-08-27 |
2002-10-23 |
Ribapharm Inc |
Analogos de nucleosido de pirrolo [2,3-d]pirimidina.
|
US6831069B2
(en)
*
|
1999-08-27 |
2004-12-14 |
Ribapharm Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
DE10142100A1
(de)
|
2001-08-30 |
2003-04-03 |
Epcos Ag |
Elektrolytlösung für Kondensatoren und ein Elektrolytkondensator mit der Elektrolytlösung sowie dessen Verwendung
|
WO2003039523A2
(en)
|
2001-11-05 |
2003-05-15 |
Exiqon A/S |
OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
|
WO2003072757A2
(en)
|
2002-02-28 |
2003-09-04 |
Biota, Inc. |
Nucleotide mimics and their prodrugs
|
JP4384918B2
(ja)
|
2002-04-18 |
2009-12-16 |
シェーリング コーポレイション |
ヒスタミンh3アンタゴニストとして有用な(1−4−ピペリジニル)ベンズイミダゾール誘導体
|
EP1494671B1
(en)
|
2002-04-18 |
2011-10-19 |
Schering Corporation |
1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
|
AU2003299519A1
(en)
|
2002-05-20 |
2004-05-04 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
AU2003259735A1
(en)
|
2002-08-08 |
2004-02-25 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
WO2004033460A1
(en)
|
2002-10-11 |
2004-04-22 |
Ligand Pharmaceuticals Incorporated |
5-cycloalkenyl 5h-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
|
WO2004050024A2
(en)
|
2002-11-27 |
2004-06-17 |
Incyte Corporation |
3-aminopyrrolidine derivatives as modulators of chemokine receptors
|
WO2004081643A1
(en)
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
BRPI0409198A
(pt)
|
2003-04-04 |
2006-05-02 |
Novartis Ag |
derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
|
JP4661029B2
(ja)
|
2003-05-22 |
2011-03-30 |
東ソー株式会社 |
光学活性マレイミド誘導体、光学活性ポリマレイミド誘導体、その製造方法、その光学活性ポリマレイミド誘導体からなる分離剤及びそれを用いた光学活性化合物の分離方法
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
KR20060123707A
(ko)
|
2003-08-27 |
2006-12-04 |
바이오타, 인코포레이티드 |
치료제로서의 신규 트리시클릭 뉴클레오시드 또는뉴클레오티드
|
US20080234498A1
(en)
|
2003-10-08 |
2008-09-25 |
President And Fellow Of Harvard College |
Pyrovalerone Analogues and Therapeutic Uses Thereof
|
US20070078120A1
(en)
|
2003-10-21 |
2007-04-05 |
Hitoshi Ban |
Novel piperidine derivative
|
WO2005060665A2
(en)
|
2003-12-18 |
2005-07-07 |
Incyte Corporation |
3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
|
AU2004309420B2
(en)
|
2003-12-23 |
2008-10-30 |
Novartis Ag |
Bicyclic heterocyclic p-38 kinase inhibitors
|
WO2005097738A1
(ja)
|
2004-04-06 |
2005-10-20 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規スルホンアミド誘導体
|
AR048523A1
(es)
|
2004-04-07 |
2006-05-03 |
Kalypsys Inc |
Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
|
US7687665B2
(en)
|
2004-06-24 |
2010-03-30 |
Incyte Corporation |
2-methylprop anamides and their use as pharmaceuticals
|
EP1616874A1
(en)
|
2004-07-14 |
2006-01-18 |
Universiteit Gent |
Mono- and bicyclic compounds with therapeutic activity and pharmaceutical compositions including them
|
JP2006124326A
(ja)
|
2004-10-28 |
2006-05-18 |
Sumitomo Chemical Co Ltd |
クロピドグレルの製造方法
|
JP2008528598A
(ja)
|
2005-01-25 |
2008-07-31 |
グラクソ グループ リミテッド |
抗菌剤
|
JP5048520B2
(ja)
|
2005-02-04 |
2012-10-17 |
ミレニアム ファーマシューティカルズ, インコーポレイテッド |
E1活性化酵素の阻害剤
|
JP2006241090A
(ja)
|
2005-03-04 |
2006-09-14 |
Tosoh Corp |
光学活性カルボン酸類の分離方法
|
AU2006222563A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
EP1866298A2
(en)
|
2005-03-31 |
2007-12-19 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
EP1896453B1
(en)
|
2005-06-20 |
2009-12-02 |
Schering Corporation |
Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
|
AU2006262441A1
(en)
|
2005-06-20 |
2007-01-04 |
Schering Corporation |
Piperidine derivatives useful as histamine H3 antagonists
|
DE102005059892A1
(de)
|
2005-12-15 |
2007-06-28 |
Bayer Cropscience Ag |
Alkylthio-spirocyclische Tetramsäuren
|
DE102005059891A1
(de)
|
2005-12-15 |
2007-06-28 |
Bayer Cropscience Ag |
3'-Alkoxy-spirocyclopentyl substituierte Tetram- und Tetronsäuren
|
WO2007075525A2
(en)
|
2005-12-20 |
2007-07-05 |
Novartis Ag |
Combination of an iap-inhibitor and a taxane7
|
BRPI0620386A2
(pt)
|
2005-12-21 |
2011-12-20 |
Schering Corp |
composição compreendendo a combinação de um antagonista de h3/agonista inverso e um supressor de apetite e uso da referida composição
|
US7612101B2
(en)
|
2006-04-24 |
2009-11-03 |
Allergan, Inc. |
Abnormal cannabidiols as agents for lowering intraocular pressure
|
AU2007244978B2
(en)
|
2006-04-24 |
2013-05-30 |
Allergan, Inc. |
Abnormal Cannabidiols as agents for lowering intraocular pressure
|
MY157177A
(en)
|
2006-08-08 |
2016-05-13 |
Millennium Pharm Inc |
Heteroaryl compounds useful as inhibitors of e1 activating enzymes
|
US8492429B2
(en)
|
2006-11-28 |
2013-07-23 |
Novartis Ag |
Combination of IAP inhibitors and FLT3 inhibitors
|
DE102006056740A1
(de)
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
|
CN101195586A
(zh)
|
2006-12-05 |
2008-06-11 |
中国科学院上海药物研究所 |
一类具有取代环戊烷结构的化合物、制备方法及其医学用途
|
WO2008077597A1
(en)
|
2006-12-22 |
2008-07-03 |
Novartis Ag |
1-aminomethyl- l- phenyl- cyclohexane derivatives as ddp-iv inhibitors
|
US8133895B2
(en)
|
2007-05-10 |
2012-03-13 |
Janssen Pharmaceutica N.V. |
Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
|
ES2758027T3
(es)
|
2007-08-02 |
2020-05-04 |
Millennium Pharm Inc |
Intermedios para la síntesis de inhibidores de enzimas activadoras de actividad E1
|
US8598165B2
(en)
|
2007-11-26 |
2013-12-03 |
University Of Kansas |
Morpholines as selective inhibitors of cytochrome P450 2A13
|
WO2009124103A2
(en)
|
2008-04-02 |
2009-10-08 |
Schering Corporation |
Combination therapies comprising par1 antagonists with par4 antagonists
|
EP2276464A2
(en)
|
2008-04-15 |
2011-01-26 |
Mallinckrodt Inc. |
Combinations of antiviral agents and other compounds
|
WO2009132453A1
(en)
|
2008-04-28 |
2009-11-05 |
Neuromed Pharmaceuticals Ltd. |
Cyclylamine derivatives as calcium channel blockers
|
WO2010030858A1
(en)
|
2008-09-15 |
2010-03-18 |
Enanta Pharmaceuticals, Inc. |
4'-allene-substituted nucleoside derivatives
|
CN102271514A
(zh)
|
2008-10-30 |
2011-12-07 |
肿瘤疗法科学股份有限公司 |
7-羟基-苯并咪唑-4-基-甲酮衍生物以及包含其的pbk抑制剂
|
WO2010054384A1
(en)
|
2008-11-10 |
2010-05-14 |
Alnylam Pharmaceuticals, Inc. |
Lipids and compositions for the delivery of therapeutics
|
SG171761A1
(en)
|
2008-11-20 |
2011-07-28 |
Oncotherapy Science Inc |
Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives
|
CN102395590A
(zh)
|
2009-02-06 |
2012-03-28 |
Rfs制药公司 |
用于治疗癌症和病毒感染的嘌呤核苷单磷酸酯前药
|
JP2012521359A
(ja)
|
2009-03-20 |
2012-09-13 |
アリオス バイオファーマ インク. |
置換されたヌクレオシドアナログおよびヌクレオチドアナログ
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
WO2011005595A2
(en)
|
2009-06-24 |
2011-01-13 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
US8927513B2
(en)
|
2009-07-07 |
2015-01-06 |
Alnylam Pharmaceuticals, Inc. |
5′ phosphate mimics
|
KR101049260B1
(ko)
|
2009-07-23 |
2011-07-13 |
주식회사 엘지화학 |
새로운 포스트 메탈로센형 전이금속 화합물
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
TW201118099A
(en)
|
2009-08-12 |
2011-06-01 |
Boehringer Ingelheim Int |
New compounds for the treatment of CNS disorders
|
EA020586B1
(ru)
|
2009-09-10 |
2014-12-30 |
Новартис Аг |
СУЛЬФОНАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ БЕЛКОВ СЕМЕЙСТВА Bcl-2, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ЛЕЧЕНИЯ РАКА
|
WO2011057204A2
(en)
|
2009-11-06 |
2011-05-12 |
The Johns Hopkins University |
Lrrk2-mediated neuronal toxicity
|
WO2011061590A1
(en)
|
2009-11-17 |
2011-05-26 |
Hetero Research Foundation |
Novel carboxamide derivatives as hiv inhibitors
|
US20130172553A1
(en)
|
2009-11-25 |
2013-07-04 |
Cpsi Stockholder Trust |
Chiral synthesis of isoxazolines, isoxazoline compounds, and uses thereof
|
CN102812003B
(zh)
|
2009-12-18 |
2015-01-21 |
欧洲筛选有限公司 |
吡咯烷羧酸衍生物、药物组合物以及在代谢紊乱中作为g-蛋白偶联受体43(gpr43)激动剂使用的方法
|
EP2536410B1
(en)
|
2010-02-18 |
2015-09-23 |
Merck Sharp & Dohme Corp. |
Substituted pyrimidine derivatives and their use in treating viral infections
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
KR101213733B1
(ko)
|
2010-04-23 |
2012-12-18 |
주식회사 엘지화학 |
신규한 촉매조성물 및 이를 이용한 올레핀 중합체의 제조방법
|
JP2013147430A
(ja)
|
2010-04-28 |
2013-08-01 |
Astellas Pharma Inc |
夜間頻尿の予防又は治療剤
|
KR20110123657A
(ko)
|
2010-05-07 |
2011-11-15 |
에스케이케미칼주식회사 |
피콜린아마이드 및 피리미딘-4-카복사미드 화합물, 이의 제조방법 및 이를 함유하는 약제학적 조성물
|
CA2801001A1
(en)
|
2010-06-01 |
2011-12-08 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
|
WO2012025857A1
(en)
|
2010-08-23 |
2012-03-01 |
Hetero Research Foundation |
Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors
|
AU2011297888A1
(en)
|
2010-09-03 |
2013-04-11 |
Grünenthal GmbH |
Substituted tetrahydropyrrolopyrazine derivatives
|
US20120070411A1
(en)
|
2010-09-22 |
2012-03-22 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
GEP20156313B
(en)
|
2010-09-22 |
2015-07-10 |
Alios Biopharma Inc |
Substituted nucleotide analogs
|
EP2621923B1
(en)
|
2010-09-29 |
2017-03-29 |
Intervet International B.V. |
N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
|
BR112013013659B8
(pt)
|
2010-12-03 |
2024-02-27 |
Epizyme Inc |
Compostos moduladores de enzimas epigenéticas, composição farmacêutica compreendendo ditos compostos e usos da dita composição farmacêutica para tratar câncer, câncer hematológico ou leucemia
|
WO2012114223A1
(en)
|
2011-02-25 |
2012-08-30 |
Pfizer Limited |
A method of treating liver fibrosis
|
EP2508511A1
(en)
|
2011-04-07 |
2012-10-10 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
MX2014000797A
(es)
|
2011-07-19 |
2014-07-09 |
Univ Idaho |
Sonda y metodo para direccionar acidos nucleicos.
|
CN102924457A
(zh)
|
2011-08-12 |
2013-02-13 |
上海恒瑞医药有限公司 |
三唑并嘧啶类衍生物、其制备方法及其用途
|
CN103814030A
(zh)
|
2011-09-22 |
2014-05-21 |
辉瑞大药厂 |
吡咯并嘧啶及嘌呤衍生物
|
CN103102345B
(zh)
|
2011-11-14 |
2015-06-03 |
广东东阳光药业有限公司 |
氨基喹唑啉类衍生物及其盐和使用方法
|
WO2013096939A1
(en)
|
2011-12-23 |
2013-06-27 |
Sri International |
Selective binding compounds
|
WO2013120040A1
(en)
|
2012-02-10 |
2013-08-15 |
Children's Medical Center Corporation |
Targeted pathway inhibition to improve muscle structure, function and activity in muscular dystrophy
|
WO2013151975A1
(en)
|
2012-04-02 |
2013-10-10 |
Northeastern University |
Compositions and methods for the inhibition of methyltransferases
|
WO2013188881A1
(en)
|
2012-06-15 |
2013-12-19 |
President And Fellows Of Harvard College |
Compounds, compositions and methods for treating or preventing neurodegenerative disorders
|
TW201408652A
(zh)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
作爲RORc調節劑之芳基磺內醯胺衍生物
|
WO2014026198A1
(en)
|
2012-08-10 |
2014-02-13 |
Epizyme, Inc. |
Inhibitors of protein methyltransferase dot1l and methods of use thereof
|
CN104926808B
(zh)
|
2012-08-24 |
2018-09-14 |
广东东阳光药业有限公司 |
二氢嘧啶类化合物及其在药物中的应用
|
RU2015119999A
(ru)
|
2012-10-29 |
2016-12-20 |
Кокристал Фарма, Инк. |
Пиримидиновые нуклеозиды и их монофосфатные пролекарства для лечения вырусных инфекций и рака
|
KR20150092764A
(ko)
|
2012-12-10 |
2015-08-13 |
에프. 호프만-라 로슈 아게 |
RORc 조절인자로서의 벤질 설폰아마이드 유도체
|
US20160045531A1
(en)
|
2013-03-14 |
2016-02-18 |
Epizyme, Inc. |
Combination therapy for treating cancer
|
EP2968233A4
(en)
|
2013-03-14 |
2016-08-03 |
Chdi Foundation Inc |
HISTON DEACETYLASE HEMMER AND COMPOSITIONS AND METHOD FOR USE THEREOF
|
AU2014239542A1
(en)
|
2013-03-15 |
2015-10-01 |
Araxes Pharma Llc |
Covalent inhibitors of KRas G12C
|
SG11201507470WA
(en)
|
2013-03-15 |
2015-10-29 |
Cayman Chemical Co Inc |
Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
|
UY35464A
(es)
|
2013-03-15 |
2014-10-31 |
Araxes Pharma Llc |
Inhibidores covalentes de kras g12c.
|
WO2015077360A2
(en)
|
2013-11-20 |
2015-05-28 |
Idenix Pharmaceuticals, Inc. |
Cyclopentane and cyclopentene nucleoside analogs for the treatment of hcv
|
TWI608080B
(zh)
|
2014-01-29 |
2017-12-11 |
達興材料股份有限公司 |
液晶化合物、液晶組成物以及液晶顯示元件
|
WO2015120237A2
(en)
*
|
2014-02-06 |
2015-08-13 |
Riboscience Llc |
4'-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza rna replication
|
RU2016149804A
(ru)
|
2014-05-23 |
2018-06-26 |
Ф. Хоффманн-Ля Рош Аг |
Производные бензолсульфонамида и их применение в качестве модуляторов орфанного рецептора y, связанного с ретиноевой кислотой
|
CN104059674B
(zh)
|
2014-06-06 |
2016-01-20 |
北京八亿时空液晶科技股份有限公司 |
一种含有二氟甲氧基桥键的液晶化合物及其应用
|
CN104087312B
(zh)
|
2014-06-17 |
2016-07-06 |
北京八亿时空液晶科技股份有限公司 |
一种液晶组合物及其应用
|
AP2016009653A0
(en)
*
|
2014-06-24 |
2016-12-31 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
AR101214A1
(es)
|
2014-07-22 |
2016-11-30 |
Bayer Cropscience Ag |
Ciano-cicloalquilpenta-2,4-dienos, ciano-cicloalquilpent-2-en-4-inas, ciano-heterociclilpenta-2,4-dienos y ciano-heterociclilpent-2-en-4-inas sustituidos como principios activos contra el estrés abiótico de plantas
|
BR112017001221A2
(pt)
|
2014-07-31 |
2017-11-28 |
Merck Patent Gmbh |
derivados de indolizina que são aplicáveis a doenças neurodegenerativas
|
JP6585158B2
(ja)
|
2014-08-12 |
2019-10-02 |
ファイザー・インク |
ヤヌスキナーゼの阻害に有用なピロロ[2,3−d]ピリミジン誘導体
|
JP2017532312A
(ja)
|
2014-09-17 |
2017-11-02 |
エピザイム,インコーポレイティド |
癌を治療するための併用療法
|
JO3556B1
(ar)
|
2014-09-18 |
2020-07-05 |
Araxes Pharma Llc |
علاجات مدمجة لمعالجة السرطان
|
WO2016049524A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
WO2016049565A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Compositions and methods for inhibition of ras
|
SG10201810361TA
(en)
*
|
2014-09-26 |
2018-12-28 |
Riboscience Llc |
4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus rna replication
|
WO2016066582A1
(en)
|
2014-10-28 |
2016-05-06 |
Bci Pharma |
Nucleoside kinase inhibitors
|
US10421696B2
(en)
|
2014-12-18 |
2019-09-24 |
California Institute Of Technology |
Enantioselective synthesis of α-quaternary mannich adducts by palladium-catalyzed allylic alkylation
|
WO2016115416A1
(en)
|
2015-01-15 |
2016-07-21 |
The Trustees Of Columbia University In The City Of New York |
Methods of producing metal suflides, metal selenides, and metal sulfides/selenides having controlled architectures using kinetic control
|
WO2016145142A1
(en)
|
2015-03-10 |
2016-09-15 |
Emory University |
Nucleotide and nucleoside therapeutics compositions and uses related thereto
|
FR3034767A1
(fr)
|
2015-04-07 |
2016-10-14 |
Centre Nat Rech Scient |
Reduction des fonctions carbonyles de glucides et derives de glucides en milieu aqueux par le dithionite de sodium
|
MX2018001592A
(es)
|
2015-08-10 |
2018-08-21 |
Alzheon Inc |
Composiciones y metodos para el tratamiento y la prevencion de trastornos neurodegenerativos.
|
TWI730980B
(zh)
|
2015-08-26 |
2021-06-21 |
比利時商健生藥品公司 |
使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物
|
US9926277B2
(en)
|
2015-10-02 |
2018-03-27 |
Biotheryx, Inc. |
Pyridone compounds, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
|
US11433047B2
(en)
|
2015-10-09 |
2022-09-06 |
Neurotheryx Canada Ltd. |
Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases
|
WO2017066791A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Sugar substituted mrna cap analogs
|
US11866754B2
(en)
|
2015-10-16 |
2024-01-09 |
Modernatx, Inc. |
Trinucleotide mRNA cap analogs
|
JP2018530587A
(ja)
|
2015-10-16 |
2018-10-18 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
mRNAキャップ類似体およびmRNAキャッピングの方法
|
WO2017066789A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Mrna cap analogs with modified sugar
|
DK3362461T3
(da)
|
2015-10-16 |
2022-05-09 |
Modernatx Inc |
Mrna-cap-analoger med modificeret phosphatbinding
|
WO2017066782A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Hydrophobic mrna cap analogs
|
WO2017099969A1
(en)
|
2015-12-10 |
2017-06-15 |
Merck Sharp & Dohme Corp. |
Tetrahydroquinoxaline m1 receptor positive allosteric modulators
|
WO2017117443A1
(en)
|
2015-12-31 |
2017-07-06 |
Braskem America, Inc. |
Non-phthalate catalyst system and its use in the polymerization of olefins
|
EP3426664B1
(en)
*
|
2016-03-10 |
2021-06-30 |
Janssen Pharmaceutica NV |
Substituted nucleoside analogues for use as prmt5 inhibitors
|
CA2969295A1
(en)
*
|
2016-06-06 |
2017-12-06 |
Pfizer Inc. |
Substituted carbonucleoside derivatives, and use thereof as a prmt5 inhibitor
|
CN109071392B
(zh)
|
2016-06-08 |
2020-10-02 |
四川海思科制药有限公司 |
苯环衍生物及其制备方法和在医药上的应用
|
WO2018022761A1
(en)
|
2016-07-27 |
2018-02-01 |
Blueprint Medicines Corporation |
Substituted cyclopentane-amides for treating disorders related to ret
|
CN107674029A
(zh)
|
2016-08-02 |
2018-02-09 |
上海迪诺医药科技有限公司 |
多环化合物、其药物组合物及应用
|
WO2018024188A1
(zh)
|
2016-08-02 |
2018-02-08 |
上海迪诺医药科技有限公司 |
多环化合物、其制备方法、药物组合物及应用
|
CN107793409B
(zh)
|
2016-09-05 |
2022-09-27 |
广东东阳光药业有限公司 |
二氢嘧啶类化合物及其在药物中的应用
|
WO2018065365A1
(en)
*
|
2016-10-03 |
2018-04-12 |
Janssen Pharmaceutica Nv |
Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors
|
WO2018065353A1
(en)
|
2016-10-03 |
2018-04-12 |
Umicore Ag & Co. Kg |
Catalyst article and method for the abatement of ammonia and nitrogen oxides
|
JP2018070512A
(ja)
|
2016-10-31 |
2018-05-10 |
住友化学株式会社 |
有害節足動物防除組成物
|
WO2018081863A1
(en)
|
2016-11-04 |
2018-05-11 |
University Of Wollongong |
6-SUBSTITUTED DERIVATIVES OF HEXAMETHYLENE AMILORIDE AS INHIBITORS OF uPA AND USES THEREOF
|
WO2018085818A1
(en)
*
|
2016-11-07 |
2018-05-11 |
Prelude Therapeutics, Incorporated |
Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
|
CN108276463A
(zh)
|
2017-01-06 |
2018-07-13 |
米文君 |
一类新的化合物及其用途
|
WO2018152501A1
(en)
|
2017-02-20 |
2018-08-23 |
Prelude Therapeutics, Incorporated |
Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
|
US11220524B2
(en)
|
2017-02-20 |
2022-01-11 |
Prelude Therapeutics Incorporated |
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
|
MX2019010150A
(es)
|
2017-02-27 |
2019-10-21 |
Janssen Pharmaceutica Nv |
Uso de biomarcadores en la identificacion de pacientes con cancer que seran sensibles al tratamiento con un inhibidor de prmt5.
|
WO2018160824A1
(en)
|
2017-03-01 |
2018-09-07 |
Prelude Therapeutics, Incorporated |
Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
|
EP3592739A1
(en)
|
2017-03-07 |
2020-01-15 |
H. Hoffnabb-La Roche Ag |
Oxadiazole transient receptor potential channel inhibitors
|
WO2018213258A1
(en)
|
2017-05-15 |
2018-11-22 |
Millennium Pharmaceuticals, Inc. |
Treatment of merlin-deficient tumors using nae inhibitors
|
JP7088965B2
(ja)
|
2017-06-09 |
2022-06-21 |
ブリストル-マイヤーズ スクイブ カンパニー |
アリール複素環ピペリジノンホルミルペプチド2受容体およびホルミルペプチド1受容体アゴニスト
|
CN111741964A
(zh)
*
|
2017-12-05 |
2020-10-02 |
安杰斯制药公司 |
作为prmt5抑制剂的杂环化合物
|
DK3724190T3
(da)
|
2017-12-13 |
2022-10-10 |
Lupin Ltd |
Substituerede bicykliske heterocykliske forbindelser som PRMT5 inhibitorer
|
KR20190076339A
(ko)
|
2017-12-22 |
2019-07-02 |
한미약품 주식회사 |
신규한 2,6-나프티리딘 2-옥시드 유도체 화합물 및 이의 용도
|
EP3765006A4
(en)
|
2018-03-13 |
2022-02-23 |
Merck Sharp & Dohme Corp. |
ARGINASE INHIBITORS AND METHODS OF USE
|
CN110386954B
(zh)
|
2018-04-16 |
2020-08-21 |
中国科学院化学研究所 |
含不对称稠环吡啶亚胺基配合物及其制备方法与应用
|
KR20210018255A
(ko)
|
2018-04-30 |
2021-02-17 |
오릭 파마슈티칼스, 인크. |
Cd73 억제제
|
US11993602B2
(en)
|
2018-08-07 |
2024-05-28 |
Merck Sharp & Dohme Llc |
PRMT5 inhibitors
|
US11981701B2
(en)
|
2018-08-07 |
2024-05-14 |
Merck Sharp & Dohme Llc |
PRMT5 inhibitors
|
MA53287A
(fr)
*
|
2018-08-07 |
2022-05-11 |
Merck Sharp & Dohme |
Inhibiteurs de prmt5
|
US20210309687A1
(en)
|
2018-08-07 |
2021-10-07 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
EP3852746B1
(en)
|
2018-09-18 |
2023-03-29 |
Bristol-Myers Squibb Company |
Cyclopentyl acids as lpa antagonists
|
CN114072407A
(zh)
*
|
2019-04-02 |
2022-02-18 |
阿里戈斯治疗公司 |
靶向prmt5的化合物
|
CN110423265A
(zh)
|
2019-04-03 |
2019-11-08 |
中国药科大学 |
一种环肽类trf2抑制剂的制备方法和用途
|